Nitric Oxide Alleviated High Salt-Induced Cardiomyocyte Apoptosis and Autophagy Independent of Blood Pressure in Rats
Yong Li1, Xiaoguang Wu1, Yukang Mao1
1Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Insights
High-salt diet causes cardiac damage and cell death, independent of blood pressure. Nitric oxide (NO) supplementation can protect heart cells from this damage by reducing apoptosis and autophagy.
Area of Science:
- Cardiovascular Science
- Molecular Biology
- Cellular Biology
Background:
- High-salt diet (HSD) is linked to cardiovascular disease.
- The direct impact of HSD on cardiac damage, independent of blood pressure, requires further investigation.
- The role of nitric oxide (NO) in mitigating HSD-induced cardiac cellular stress is not fully understood.
Purpose of the Study:
- To determine if HSD induces cardiac damage independently of blood pressure.
- To investigate the effect of NO on high-salt-induced cardiomyocyte apoptosis and autophagy.
Main Methods:
- Rats were subjected to an 8% HSD.
- H9C2 cells and primary neonatal rat cardiomyocytes (NRCM) were treated with sodium chloride (NaCl) in vitro.
- Levels of apoptosis markers (cleaved-caspase 3/8, Bax/Bcl2) and autophagy markers (LC3 II/I, Beclin-1, ATG7) were measured.
- Nitric oxide donor sodium nitroprusside (SNP) was used to assess NO's protective effects.
Main Results:
- HSD increased cardiac apoptosis and autophagy markers in rats, irrespective of hypertension status.
- NaCl treatment elevated apoptosis and autophagy markers in H9C2 cells and NRCM.
- NO levels were reduced in HSD rats, while eNOS expression was altered.
- SNP administration reversed NaCl-induced apoptosis and autophagy in vitro and in vivo, without affecting blood pressure in hypertension-resistant rats.
Conclusions:
- High-salt diet promotes cardiac damage and cellular stress (apoptosis and autophagy) independently of elevated blood pressure.
- Exogenous nitric oxide supplementation can effectively alleviate high-salt-induced cardiomyocyte apoptosis and autophagy.
- These findings highlight NO's potential therapeutic role in managing salt-induced cardiac pathology.
Abstract:
The present study aimed to explore whether high-salt diet (HSD) could cause cardiac damage independent of blood pressure, and whether nitric oxide (NO) could alleviate high-salt-induced cardiomyocyte apoptosis and autophagy in rats. The rats received 8% HSD in vivo. H9C2 cells or primary neonatal rat cardiomyocytes (NRCM) were treated with sodium chloride (NaCl) in vitro. The levels of cleaved-caspase 3/caspase 3, cleaved-caspase 8/caspase 8, Bax/Bcl2, LC3 II/LC3 I, Beclin-1 and autophagy related 7 (ATG7) were increased in the heart of HSD rats with hypertension (HTN), and in hypertension-prone (HP) and hypertension-resistant (HR) rats. Middle and high doses (50 and 100 mM) of NaCl increased the level of cleaved-caspase 3/caspase 3, cleaved-caspase 8/caspase 8, Bax/Bcl2, LC3 II/LC3 I, Beclin-1, and ATG7 in H9C2 cells and NRCM. The endothelial NO synthase (eNOS) level was increased, but p-eNOS level was reduced in the heart of HSD rats and H9C2 cells treated with 100 mM NaCl. The level of NO was reduced in the serum and heart of HSD rats. NO donor sodium nitroprusside (SNP) reversed the increases of cleaved-caspase 3/caspase 3, cleaved-caspase 8/caspase 8, Bax/Bcl2 induced by NaCl (100 mM) in H9C2 cells and NRCM. SNP treatment attenuated the increases of cleaved-caspase 3/caspase 3, Bax/Bcl2, LC3 II/LC3 I, Beclin-1, and ATG7 in the heart, but had no effect on the blood pressure of HSD rats with HR. These results demonstrated that HSD enhanced cardiac damage independently of blood pressure. Exogenous NO supplementarity could alleviate the high salt-induced apoptosis and autophagy in cardiomyocytes.
Related Concept Videos
Nitric Oxide Signaling Pathway
Antihypertensive Drugs: Vasodilators
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Hypertension II: Pathophysiology


